Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of ...

Today, the American Kidney Fund (AKF) is kicking off its seventh annual Kidney Action Week®, the only free, virtual conference in the country that brings together members of the kidney ...

Arcus Biosciences (NYSE:RCUS) reported positive late stage efficacy results for casdatifan, its investigational HIF-2a inhibitor, in late line renal cell carcinoma. The company released biomarker ...

US pharma major Merck (NYSE: MRK) has reported a Phase III success for Welireg (belzutifan) plus Keytruda (pembrolizumab) as ...

High-protein diets are a frequent topic in clinics, sparking concerns about kidney harm for some and perceived benefits for others. The reality is nuanced, with the source and quantity of protein, as ...

Emcure Pharmaceuticals today announced the signing of a distribution agreement with Roche for select products in the ...

Trichy: As organ donations across Tamil Nadu witness an unprecedented surge in the first two months of this year, Mahatma Gandhi Memorial Government H.

Enbumyst™ Is the First and Only FDA-Approved Nasal Spray Loop Diuretic for Edema Associated with Congestive Heart Failure, Expected to ...

Rajji Mehdwan, Managing Director and CEO of Roche India & Neighbouring Markets, said that Emcure’s robust distribution network and clinical engagement will help ensure these medicines are accessible ...

Esperion and Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated with ...

Esperion (ESPR) to buy Corstasis for $75M upfront, adding FDA-approved Enbumyst nasal diuretic and milestone payouts—see deal terms and 2026 close details.

Lowered Inhibitions: Alcohol lowers inhibitions, which can result in overeating and consumption.